KCAT	Human spumaretrovirus	0.0002	VPTINNVHTS	*pH 6.6, 37&deg;C
KCAT	Human spumaretrovirus	0.001	SRAVYTITPE	*pH 6.6, 37&deg;C
KCAT	Human spumaretrovirus	0.0017	SRAVNTVTQS	*T28D mutant
KCAT	Human spumaretrovirus	0.002	IHLIAAVKAV	*pH 6.6, 37&deg;C
KCAT	Human spumaretrovirus	0.003	GSYVVNCNTKK	*pH 6.6, 37&deg;C
KCAT	Human spumaretrovirus	0.0031	SRAVNTVTQS	*S25T mutant
KCAT	Human spumaretrovirus	0.0053	SRAVNTVTQS	*wild-type
KCAT	Human spumaretrovirus	0.006	SRAVNTVTOS	*pH 6.6, 37&deg;C
KCAT	Human spumaretrovirus	0.0061	SRAVNTVTQS	*Q8R mutant
KCAT	Human spumaretrovirus	0.0071	SRAVNTVTQS	*Q8R/T28D double mutant
KM	Human spumaretrovirus	-999	more	*kinetics with synthetic peptide substrates
KM	Human spumaretrovirus	-999	more	*kinetics with Gag protein-derived peptides substrates mimicking the cleavage sites
KM	Human spumaretrovirus	0.03	VPTINNVHTS	*pH 6.6, 37&deg;C
KM	Human spumaretrovirus	0.15	SRAVYTITPE	*pH 6.6, 37&deg;C
KM	Human spumaretrovirus	0.17	SRAVNTVTQS	*Q8R/T28D double mutant
KM	Human spumaretrovirus	0.26	SRAVNTVTQS	*S25T mutant
KM	Human spumaretrovirus	0.35	SRAVNTVTQS	*T28D mutant
KM	Human spumaretrovirus	0.41	SRAVNTVTQS	*wild-type
KM	Human spumaretrovirus	0.56	SRAVNTVTOS	*pH 6.6, 37&deg;C
KM	Human spumaretrovirus	0.91	GSYVVNCNTKK	*pH 6.6, 37&deg;C
KM	Human spumaretrovirus	1	IHLIAAVKAV	*pH 6.6, 37&deg;C
KM	Human spumaretrovirus	1.3	SRAVNTVTQS	*Q8R mutant
MW	Human spumaretrovirus	10000	*	*2 * 10000, SDS-PAGE
MW	Human spumaretrovirus	24500	*	*x * 24500, recombinant enzyme, SDS-PAGE
MW	prototype foamy virus	84500	*	*gel filtration
MW	prototype foamy virus	86500	*	*1 * 86500, calculated
MW	Simian foamy virus	87500	*	*x * 87500, HPLC followed by light scattering
SA	Human spumaretrovirus	-999	*	*sequence at the cleavage sites in wild-type Human foamy virus and in cleavage site mutants indicated, generation of Pol cleavage site mutants, expression and cleavage activity of Human foamy virus protease PR analyzed by Western Blot, reduced levels of PR activity observed, association between reduced enzyme activity and defects in replication of cleavage site mutant viruses shown
SA	Human spumaretrovirus	-999	*	*pH optima and protein stability in Human foamy virus protease PR in comparison with Human immunodeficiency virus type 1 protease PR analyzed, specificity constant of most mutants found to be lower, value of the Q8R-T28D double mutant enzyme found to be higher than that of the wild-type protein, mutated residues not found to be responsible for higher pH optimum of Human foamy virus protease PR, but may contribute to the lower dimer stability as compared with that of Human immunodeficiency virus type 1 protease PR, structure analysis by molecular modelling presented
